{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:28:55Z","timestamp":1782397735390,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,30]]},"DOI":"10.7759\/cureus.91287","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:23:46Z","timestamp":1756563826000},"source":"Crossref","is-referenced-by-count":1,"title":["Pattern and Distribution of Skeletal Metastases in Patients With Prostate Cancer in Ghana: A Descriptive Analysis and a Model-Based Digital Nomogram for Oligo-Ostotic Versus Polyostotic Metastases"],"prefix":"10.7759","author":[{"given":"Frank","family":"Obeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Korsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Fadil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godson","family":"Agbeteti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obed K","family":"Amenyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N","family":"Okai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"Seshie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jephtha","family":"Owusu Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice","family":"Dzomeku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nii-Boye","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis CJ","year":"2005","unstructured":"Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. 2005, 5:21-8. 10.1038\/nrc1528","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy GR","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002, 2:584-93. 10.1038\/nrc867","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf L","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, et al.. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000, 31:578-83. 10.1053\/hp.2000.6698","journal-title":"Hum Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hym097","article-title":"Bone scanning--who needs it among patients with newly diagnosed prostate cancer?","volume":"37","author":"Hirobe M","year":"2007","unstructured":"Hirobe M, Takahashi A, Hisasue S, et al.. Bone scanning--who needs it among patients with newly diagnosed prostate cancer?. Jpn J Clin Oncol. 2007, 37:788-92. 10.1093\/jjco\/hym097","journal-title":"Jpn J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4314\/aas.v15i1.2","article-title":"Can PSA predict bone metastasis amongst newly diagnosed prostate cancer patients?","volume":"15","author":"Ojuka D","year":"2018","unstructured":"Ojuka D, Majicha S, Ngugi P. Can PSA predict bone metastasis amongst newly diagnosed prostate cancer patients?. Ann Afr Surg. 2018, 15:6-9. 10.4314\/aas.v15i1.2","journal-title":"Ann Afr Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-55382010000600006","article-title":"Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study","volume":"36","author":"Al-Ghazo MA","year":"2010","unstructured":"Al-Ghazo MA, Ghalayini IF, Al-Azab RS, Bani-Hani I, Barham A, Haddad Y. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study. Int Braz J Urol. 2010, 36:685-91; discussion 691-2. 10.1590\/s1677-55382010000600006","journal-title":"Int Braz J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka T","year":"2004","unstructured":"Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004, 22:2942-53. 10.1200\/JCO.2004.08.181","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.627379","article-title":"Metastatic spread in prostate cancer patients influencing radiotherapy response","volume":"10","author":"Klusa D","year":"2020","unstructured":"Klusa D, Lohaus F, Furesi G, et al.. Metastatic spread in prostate cancer patients influencing radiotherapy response. Front Oncol. 2020, 10:627379. 10.3389\/fonc.2020.627379","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.19627.45606","article-title":"Predicting bone metastasis in prostate cancer patients using total serum prostate specific antigen (PSA) and serum alkaline phosphatase (ALP)\u2014a study at the Korle-Bu Teaching Hospital, Accra","author":"Obeng F","year":"2024","unstructured":"Obeng F, Box P. Predicting bone metastasis in prostate cancer patients using total serum prostate specific antigen (PSA) and serum alkaline phosphatase (ALP)\u2014a study at the Korle-Bu Teaching Hospital, Accra. 2024, 10.13140\/RG.2.2.19627.45606"},{"key":"ref10","article-title":"Is nuclear medicine bone scanning necessary for staging Gleason 7 prostate cancer, in the asymptomatic man with a PSA less than 20?","volume":"2","author":"HR Patel","year":"2018","unstructured":"HR Patel, C Barber, J Virdi, M Arya. Is nuclear medicine bone scanning necessary for staging Gleason 7 prostate cancer, in the asymptomatic man with a PSA less than 20?. Ann Urol Res. 2018, 2:1015.","journal-title":"Ann Urol Res"},{"key":"ref11","unstructured":"Prostate cancer. (2023). https.\/\/uroweb.org\/guidelines\/prostate-cancer."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2019.32.15.14417","article-title":"Unusual presentation of advanced prostate cancer in a black population of South-Western Nigeria","volume":"32","author":"Salako A","year":"2019","unstructured":"Salako A, Badmus T, Komolafe A, et al.. Unusual presentation of advanced prostate cancer in a black population of South-Western Nigeria. Pan Afr Med J. 2019, 32:15. 10.11604\/pamj.2019.32.15.14417","journal-title":"Pan Afr Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.09.004","article-title":"Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature","volume":"67","author":"Ost P","year":"2015","unstructured":"Ost P, Bossi A, Decaestecker K, et al.. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2015, 67:852-63. 10.1016\/j.eururo.2014.09.004","journal-title":"Eur Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186767","article-title":"Prostate-specific membrane antigen ligands for imaging and therapy","volume":"58","author":"Eiber M","year":"2017","unstructured":"Eiber M, Fendler WP, Rowe SP, et al.. Prostate-specific membrane antigen ligands for imaging and therapy. J Nucl Med. 2017, 58:67S-76S. 10.2967\/jnumed.116.186767","journal-title":"J Nucl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2013.15.129.2489","article-title":"Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination","volume":"15","author":"Ikuerowo SO","year":"2013","unstructured":"Ikuerowo SO, Omisanjo OA, Bioku MJ, Ajala MO, Mordi VP, Esho JO. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan Afr Med J. 2013, 15:129. 10.11604\/pamj.2013.15.129.2489","journal-title":"Pan Afr Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14192229","article-title":"SuperScan pattern on bone scintigraphy: a comprehensive review","volume":"14","author":"Askari E","year":"2024","unstructured":"Askari E, Shakeri S, Roustaei H, Fotouhi M, Sadeghi R, Harsini S, Vali R. SuperScan pattern on bone scintigraphy: a comprehensive review. Diagnostics (Basel). 2024, 14:2229. 10.3390\/diagnostics14192229","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87786","article-title":"Predicting bone metastasis in prostate cancer patients using total serum prostate-specific antigen and serum alkaline phosphatase: model development, validation, and deployment as a digital risk estimator","volume":"17","author":"Obeng F","year":"2025","unstructured":"Obeng F, Yawson A, Hammond NB, et al.. Predicting bone metastasis in prostate cancer patients using total serum prostate-specific antigen and serum alkaline phosphatase: model development, validation, and deployment as a digital risk estimator. Cureus. 2025, 17:e87786. 10.7759\/cureus.87786","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S174237","article-title":"Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis","volume":"10","author":"Li D","year":"2018","unstructured":"Li D, Lv H, Hao X, Hu B, Song Y. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis. Cancer Manag Res. 2018, 10:3125-39. 10.2147\/CMAR.S174237","journal-title":"Cancer Manag Res"},{"key":"ref19","article-title":"Prostate carcinoma staging: clinical utility of bone alkaline phosphatase in addition to prostate specific antigen","volume":"1","author":"Morote J","year":"1996","unstructured":"Morote J, Lorente JA, Encabo G. Prostate carcinoma staging: clinical utility of bone alkaline phosphatase in addition to prostate specific antigen. Cancer. 1996, 1:2374-8.","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico AV","year":"1998","unstructured":"D'Amico AV, Whittington R, Malkowicz SB, et al.. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 280:969-74. 10.1001\/jama.280.11.969","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein JI","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD, et al.. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016, 69:428-35. 10.1016\/j.eururo.2015.06.046","journal-title":"Eur Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma","volume":"41","author":"Epstein JI","year":"2017","unstructured":"Epstein JI, Amin MB, Reuter VE, Humphrey PA. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2017, 41:e1-7. 10.1097\/PAS.0000000000000820","journal-title":"Am J Surg Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin MB","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al.. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017, 67:93-9. 10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4","article-title":"AJCC Cancer Staging Manual","author":"American Joint Committee on Cancer","year":"2002","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual. Greene FL, Page DL, Fleming ID, et al. (ed): Springer, Berlin, Germany; 2002. 10.1007\/978-1-4757-3656-4"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers AJ","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26:565-74. 10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"key":"ref26","unstructured":"Superscan Risk Calculator. clinical decision support tool for bone scan recommendations. (2025). Accessed: August 23, 2025: https:\/\/raw.githack.com\/qwabsfiles\/healthtools\/main\/superscan.html ."},{"key":"ref27","unstructured":"Superscan Risk Calculator. clinical decision support tool for bone scan recommendations (Website 2). (2025). Accessed: August 23, 2025: https:\/\/innohealthtoolsuroletalgh.com\/superscan.html."},{"key":"ref28","unstructured":"Refined Superscan Calculator (Ms. Excel Version). (2025). Accessed. August 23, 2025: https:\/\/docs.google.com\/spreadsheets\/d\/1E-0JT-sfiTaDi8EgeEQ2ST8fQTq9MVnu\/edit?usp=drive_link&ouid=1167394626556361429...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391941-pattern-and-distribution-of-skeletal-metastases-in-patients-with-prostate-cancer-in-ghana-a-descriptive-analysis-and-a-model-based-digital-nomogram-for-oligo-ostotic-versus-polyostotic-metastases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:23:47Z","timestamp":1756563827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391941-pattern-and-distribution-of-skeletal-metastases-in-patients-with-prostate-cancer-in-ghana-a-descriptive-analysis-and-a-model-based-digital-nomogram-for-oligo-ostotic-versus-polyostotic-metastases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.91287","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}